Tag: AstraZeneca

AstraZeneca abandons U.S. application for COVID-19 vaccine, halts development of multiple drugs

ADC评论 November 11, 2022

On November 10, when AstraZeneca announced its third-quarter 2022 results, it also announced that it would not submit a listing application for the new crown

AstraZeneca’s Akt inhibitor successful in phase III study in breast cancer

ADC评论 October 27, 2022

On October 26, AstraZeneca announced that the Phase III CAPItello-291 study of its Akt1/2/3 inhibitor capivasertib in combination with fulvestrant in breast cancer patients met

AstraZeneca: Dapagliflozin significantly reduces mortality in people with heart failure

ADC评论 August 30, 2022

On August 27, AstraZeneca updated the analysis results of the Phase III DAPA-HF and DELIVER studies, compared with placebo, dapagliflozin (brand name: Farxiga) can significantly